Back to Search Start Over

Novel heterozygous VPS13A pathogenic variants in chorea-neuroacanthocytosis: a case report.

Authors :
Chen X
Zhang P
Wang L
Zhang Y
Source :
BMC neurology [BMC Neurol] 2023 Oct 04; Vol. 23 (1), pp. 350. Date of Electronic Publication: 2023 Oct 04.
Publication Year :
2023

Abstract

Background: Chorea-acanthocytosis (ChAc) is a rare hereditary autosomal recessive neurodegenerative disorder caused by pathogenic variants of the Vacuolar Protein Sorting 13 homolog A (VPS13A) gene. The variant spectrum of VPS13A has not been completely elucidated. This study reports two novel heterozygous VPS13A pathogenic variants in ChAc that expand the variant spectrum of VPS13A.<br />Case Presentation: We described a case of a 29-year-old man with typical clinical manifestations of ChAc, including chorea, orofacial lingual dyskinesia, vocal tics, elevated serum biochemical indicators, increased acanthocytes in peripheral blood, and caudate nucleus atrophy. Next-generation sequencing revealed two heterozygous variants of VPS13A: a nonsense variant (NM_033305.2: c.8215G > T, p. Glu2739Ter) and a deletion variant in the exons 25-31.<br />Conclusion: The identified nonsense variant gives rise to premature translation termination, while the deletion variant is expected to cause a significant in-frame deletion of amino acid residues in the encoded protein. Both variants are considered to be pathogenic and result in loss-of-function proteins. These findings have implications for the genetic counseling of patients with VPS13A variants.<br /> (© 2023. BioMed Central Ltd., part of Springer Nature.)

Details

Language :
English
ISSN :
1471-2377
Volume :
23
Issue :
1
Database :
MEDLINE
Journal :
BMC neurology
Publication Type :
Academic Journal
Accession number :
37794323
Full Text :
https://doi.org/10.1186/s12883-023-03398-x